Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Kilgourmd Inc. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by a single distinct examiner, MILLER, MAKENNA RYLEIGH, who is the busiest examiner for the portfolio. The portfolio is currently limited to a single distinct art unit, indicating a concentrated technical focus for the pending patent application. This centralization simplifies the administrative burden of tracking the application's progress through the patent office.
The busiest examiner pending count of 1 confirms that MILLER, MAKENNA RYLEIGH is the sole examiner responsible for the current pending workload. This examiner's perspective on the biotechnology and pharmaceutical claims will be the deciding factor for the application's success. With only a single distinct examiner and art unit, the company can focus its legal strategy on the specific preferences and prior art interpretations of a single individual. This prosecution profile suggests a very targeted entry into the biotechnology patent landscape.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, MAKENNA RYLEIGH | 1 | 100.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18535563 | METHOD TO PREVENT OXIDATIVE STRESS IN THE SKIN OF THE SCALP THROUGH THE COMBINATION OF L-ASCORBIC ACID WITH ANTI-FUNGAL AGENTS | MILLER, MAKENNA RYLEIGH | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18535563 | METHOD TO PREVENT OXIDATIVE STRESS IN THE SKIN OF THE SCALP THROUGH THE COMBINATION OF L-ASCORBIC ACID WITH ANTI-FUNGAL AGENTS | MILLER, MAKENNA RYLEIGH | 1611 | §103 | Final Rejection | — | Pending | Dec 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKilgourmd Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Makenna Ryleigh Miller has the most, with 1 of Kilgourmd Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.